119 related articles for article (PubMed ID: 38040684)
21. Characterizing SH2 Domain Specificity and Network Interactions Using SPOT Peptide Arrays.
Liu BA
Methods Mol Biol; 2017; 1555():357-373. PubMed ID: 28092043
[TBL] [Abstract][Full Text] [Related]
22. NMR structure of the N-SH2 of the p85 subunit of phosphoinositide 3-kinase complexed to a doubly phosphorylated peptide reveals a second phosphotyrosine binding site.
Weber T; Schaffhausen B; Liu Y; Günther UL
Biochemistry; 2000 Dec; 39(51):15860-9. PubMed ID: 11123912
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and evaluation of phosphopeptides containing iminodiacetate groups as binding ligands of the Src SH2 domain.
Ye G; Schuler AD; Ahmadibeni Y; Morgan JR; Faruqui A; Huang K; Sun G; Zebala JA; Parang K
Bioorg Chem; 2009 Aug; 37(4):133-42. PubMed ID: 19539345
[TBL] [Abstract][Full Text] [Related]
24. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
Lombardo CR; Consler TG; Kassel DB
Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
[TBL] [Abstract][Full Text] [Related]
25. Identification of phosphopeptide ligands for the Src-homology 2 (SH2) domain of Grb2 by phage display.
Gram H; Schmitz R; Zuber JF; Baumann G
Eur J Biochem; 1997 Jun; 246(3):633-7. PubMed ID: 9219519
[TBL] [Abstract][Full Text] [Related]
26. Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62.
Marengere LE; Pawson T
J Biol Chem; 1992 Nov; 267(32):22779-86. PubMed ID: 1385407
[TBL] [Abstract][Full Text] [Related]
27. Structural insight into the binding diversity between the Tyr-phosphorylated human ephrinBs and Nck2 SH2 domain.
Ran X; Song J
J Biol Chem; 2005 May; 280(19):19205-12. PubMed ID: 15764601
[TBL] [Abstract][Full Text] [Related]
28. In vitro characterization of major ligands for Src homology 2 domains derived from protein tyrosine kinases, from the adaptor protein SHC and from GTPase-activating protein in Ramos B cells.
Baumann G; Maier D; Freuler F; Tschopp C; Baudisch K; Wienands J
Eur J Immunol; 1994 Aug; 24(8):1799-807. PubMed ID: 7519995
[TBL] [Abstract][Full Text] [Related]
29. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.
Hampel K; Kaufhold I; Zacharias M; Böhmer FD; Imhof D
ChemMedChem; 2006 Aug; 1(8):869-77. PubMed ID: 16902940
[TBL] [Abstract][Full Text] [Related]
30. Physical and functional interactions between SH2 and SH3 domains of the Src family protein tyrosine kinase p59fyn.
Panchamoorthy G; Fukazawa T; Stolz L; Payne G; Reedquist K; Shoelson S; Songyang Z; Cantley L; Walsh C; Band H
Mol Cell Biol; 1994 Sep; 14(9):6372-85. PubMed ID: 7520528
[TBL] [Abstract][Full Text] [Related]
31. SH2 domain binding to phosphopeptide ligands: potential for drug targeting.
Kasembeli MM; Xu X; Tweardy DJ
Front Biosci (Landmark Ed); 2009 Jan; 14(3):1010-22. PubMed ID: 19273114
[TBL] [Abstract][Full Text] [Related]
32. A screening method of SH2 domain ligands and blockers using a solid phase binding.
Koh WS; Yoon SY; Lee EK; Lee EK; Kwon BM; Kim JW; Han MY
Cancer Lett; 1997 Nov; 120(1):1-7. PubMed ID: 9570379
[TBL] [Abstract][Full Text] [Related]
33. Src binds cortactin through an SH2 domain cystine-mediated linkage.
Evans JV; Ammer AG; Jett JE; Bolcato CA; Breaux JC; Martin KH; Culp MV; Gannett PM; Weed SA
J Cell Sci; 2012 Dec; 125(Pt 24):6185-97. PubMed ID: 23097045
[TBL] [Abstract][Full Text] [Related]
34. Correlation of the phosphorylation states of pp60c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated.
Boerner RJ; Kassel DB; Barker SC; Ellis B; DeLacy P; Knight WB
Biochemistry; 1996 Jul; 35(29):9519-25. PubMed ID: 8755732
[TBL] [Abstract][Full Text] [Related]
35. FcgammaRII tyrosine phosphorylation differs between FcgammaRII cross-linking and platelet-activating anti-platelet monoclonal antibodies.
Qi R; Ozaki Y; Asazuma N; Satoh K; Yatomi Y; Law CL; Hato T; Nomura S
Biochim Biophys Acta; 1999 Sep; 1451(2-3):353-63. PubMed ID: 10556589
[TBL] [Abstract][Full Text] [Related]
36. Protein tyrosine phosphatase SHP2/PTPN11 mistargeting as a consequence of SH2-domain point mutations associated with Noonan Syndrome and leukemia.
Müller PJ; Rigbolt KT; Paterok D; Piehler J; Vanselow J; Lasonder E; Andersen JS; Schaper F; Sobota RM
J Proteomics; 2013 Jun; 84():132-47. PubMed ID: 23584145
[TBL] [Abstract][Full Text] [Related]
37. Solution structure of SHIP2 SH2 domain and its interaction with a phosphotyrosine peptide from c-MET.
Wang Z; Nie Y; Zhang K; Xu H; Ramelot TA; Kennedy MA; Liu M; Zhu J; Yang Y
Arch Biochem Biophys; 2018 Oct; 656():31-37. PubMed ID: 30165040
[TBL] [Abstract][Full Text] [Related]
38. ZAP-70 binding specificity to T cell receptor tyrosine-based activation motifs: the tandem SH2 domains of ZAP-70 bind distinct tyrosine-based activation motifs with varying affinity.
Isakov N; Wange RL; Burgess WH; Watts JD; Aebersold R; Samelson LE
J Exp Med; 1995 Jan; 181(1):375-80. PubMed ID: 7528772
[TBL] [Abstract][Full Text] [Related]
39. Structural and biochemical evaluation of the interaction of the phosphatidylinositol 3-kinase p85alpha Src homology 2 domains with phosphoinositides and inositol polyphosphates.
Surdo PL; Bottomley MJ; Arcaro A; Siegal G; Panayotou G; Sankar A; Gaffney PR; Riley AM; Potter BV; Waterfield MD; Driscoll PC
J Biol Chem; 1999 May; 274(22):15678-85. PubMed ID: 10336465
[TBL] [Abstract][Full Text] [Related]
40. Side-chain dynamics of the SAP SH2 domain correlate with a binding hot spot and a region with conformational plasticity.
Finerty PJ; Muhandiram R; Forman-Kay JD
J Mol Biol; 2002 Sep; 322(3):605-20. PubMed ID: 12225753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
